Express Scripts Holding Co. Insider Trading for March 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Express Scripts Holding Co..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Express Scripts Holding Co. for March 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17 2014 | ESRX | Express Scripts Ho ... | Wimberly Gary | Sr. VP & Ch. Inform ... | Option Exercise | M | 49.50 | 26,468 | 1,310,166 | 0 | |
| Mar 17 2014 | ESRX | Express Scripts Ho ... | Wimberly Gary | Sr. VP & Ch. Inform ... | Option Exercise | M | 31.92 | 8,068 | 257,531 | 0 | |
| Mar 17 2014 | ESRX | Express Scripts Ho ... | Wimberly Gary | Sr. VP & Ch. Inform ... | Sell | S | 78.41 | 44,497 | 3,489,099 | 13,660 | 58.2 K to 13.7 K (-76.51 %) |
| Mar 17 2014 | ESRX | Express Scripts Ho ... | Wimberly Gary | Sr. VP & Ch. Inform ... | Buy | M | 49.50 | 26,468 | 1,310,166 | 58,157 | 31.7 K to 58.2 K (+83.52 %) |
| Mar 17 2014 | ESRX | Express Scripts Ho ... | Wimberly Gary | Sr. VP & Ch. Inform ... | Buy | M | 31.92 | 8,068 | 257,531 | 31,689 | 23.6 K to 31.7 K (+34.16 %) |
| Mar 14 2014 | ESRX | Express Scripts Ho ... | Houston Christine | Sr. Vice President, ... | Option Exercise | M | 31.92 | 12,028 | 383,934 | 0 | |
| Mar 14 2014 | ESRX | Express Scripts Ho ... | Houston Christine | Sr. Vice President, ... | Option Exercise | M | 31.92 | 3,646 | 116,380 | 0 | |
| Mar 14 2014 | ESRX | Express Scripts Ho ... | Houston Christine | Sr. Vice President, ... | Sell | S | 78.53 | 19,757 | 1,551,458 | 18,314 | 38.1 K to 18.3 K (-51.90 %) |
| Mar 14 2014 | ESRX | Express Scripts Ho ... | Houston Christine | Sr. Vice President, ... | Buy | M | 31.92 | 12,028 | 383,934 | 38,071 | 26 K to 38.1 K (+46.19 %) |
| Mar 14 2014 | ESRX | Express Scripts Ho ... | Houston Christine | Sr. Vice President, ... | Buy | M | 31.92 | 3,646 | 116,380 | 26,043 | 22.4 K to 26 K (+16.28 %) |
| Mar 13 2014 | ESRX | Express Scripts Ho ... | IGNACZAK EDWARD B | Exec. VP, Sales and ... | Option Exercise | M | 53.05 | 13,680 | 725,724 | 0 | |
| Mar 13 2014 | ESRX | Express Scripts Ho ... | IGNACZAK EDWARD B | Exec. VP, Sales and ... | Option Exercise | M | 53.05 | 41,434 | 2,198,074 | 20,719 | |
| Mar 13 2014 | ESRX | Express Scripts Ho ... | IGNACZAK EDWARD B | Exec. VP, Sales and ... | Option Exercise | M | 58.17 | 16,016 | 931,651 | 32,032 | |
| Mar 13 2014 | ESRX | Express Scripts Ho ... | IGNACZAK EDWARD B | Exec. VP, Sales and ... | Option Exercise | M | 56.50 | 49,117 | 2,775,111 | 0 | |
| Mar 13 2014 | ESRX | Express Scripts Ho ... | IGNACZAK EDWARD B | Exec. VP, Sales and ... | Sell | S | 78.54 | 120,247 | 9,443,839 | 85,882 | 206.1 K to 85.9 K (-58.34 %) |
| Mar 13 2014 | ESRX | Express Scripts Ho ... | IGNACZAK EDWARD B | Exec. VP, Sales and ... | Buy | M | 53.05 | 13,680 | 725,724 | 206,129 | 192.4 K to 206.1 K (+7.11 %) |
| Mar 13 2014 | ESRX | Express Scripts Ho ... | IGNACZAK EDWARD B | Exec. VP, Sales and ... | Buy | M | 53.05 | 41,434 | 2,198,074 | 192,449 | 151 K to 192.4 K (+27.44 %) |
| Mar 13 2014 | ESRX | Express Scripts Ho ... | IGNACZAK EDWARD B | Exec. VP, Sales and ... | Buy | M | 58.17 | 16,016 | 931,651 | 151,015 | 135 K to 151 K (+11.86 %) |
| Mar 13 2014 | ESRX | Express Scripts Ho ... | IGNACZAK EDWARD B | Exec. VP, Sales and ... | Buy | M | 56.50 | 49,117 | 2,775,111 | 134,999 | 85.9 K to 135 K (+57.19 %) |
| Mar 13 2014 | ESRX | Express Scripts Ho ... | Norton David A | Senior VP, Supply C ... | Sell | S | 79.16 | 1,580 | 125,076 | 630 | 2.2 K to 630 (-71.49 %) |
| Mar 13 2014 | ESRX | Express Scripts Ho ... | Norton David A | Senior VP, Supply C ... | Sell | S | 79.14 | 1,580 | 125,048 | 646 | 2.2 K to 646 (-70.98 %) |
| Mar 12 2014 | ESRX | Express Scripts Ho ... | Miller Steven B | Sr. VP & Chief Med. ... | Sell | S | 77.96 | 12,664 | 987,298 | 21,417 | 34.1 K to 21.4 K (-37.16 %) |
| Mar 12 2014 | ESRX | Express Scripts Ho ... | McNamee Patrick | Exec. VP and COO | Sell | S | 78.22 | 27,981 | 2,188,562 | 7,664 | 35.6 K to 7.7 K (-78.50 %) |
| Mar 12 2014 | ESRX | Express Scripts Ho ... | McNamee Patrick | Exec. VP and COO | Sell | S | 78.32 | 40,444 | 3,167,695 | 12,421 | 52.9 K to 12.4 K (-76.50 %) |
| Mar 11 2014 | ESRX | Express Scripts Ho ... | Stettin Glen D. | Sr. VP, Clin. Res. ... | Option Exercise | M | 47.61 | 21,800 | 1,037,898 | 43,413 | |
| Mar 11 2014 | ESRX | Express Scripts Ho ... | Stettin Glen D. | Sr. VP, Clin. Res. ... | Option Exercise | M | 46.49 | 15,631 | 726,685 | 0 | |
| Mar 11 2014 | ESRX | Express Scripts Ho ... | Stettin Glen D. | Sr. VP, Clin. Res. ... | Sell | S | 78.21 | 43,267 | 3,383,912 | 19,857 | 63.1 K to 19.9 K (-68.54 %) |
| Mar 11 2014 | ESRX | Express Scripts Ho ... | Stettin Glen D. | Sr. VP, Clin. Res. ... | Sell | S | 78.65 | 500 | 39,327 | 63,124 | 63.6 K to 63.1 K (-0.79 %) |
| Mar 11 2014 | ESRX | Express Scripts Ho ... | Stettin Glen D. | Sr. VP, Clin. Res. ... | Buy | M | 47.61 | 21,800 | 1,037,898 | 63,624 | 41.8 K to 63.6 K (+52.12 %) |
| Mar 11 2014 | ESRX | Express Scripts Ho ... | Stettin Glen D. | Sr. VP, Clin. Res. ... | Buy | M | 46.49 | 15,631 | 726,685 | 41,824 | 26.2 K to 41.8 K (+59.68 %) |
| Mar 11 2014 | ESRX | Express Scripts Ho ... | Ebling Keith J. | Exec. VP and Gen. C ... | Option Exercise | M | 49.50 | 9,901 | 490,050 | 0 | |
| Mar 11 2014 | ESRX | Express Scripts Ho ... | Ebling Keith J. | Exec. VP and Gen. C ... | Sell | S | 79.00 | 9,582 | 756,978 | 20,000 | 29.6 K to 20 K (-32.39 %) |
| Mar 11 2014 | ESRX | Express Scripts Ho ... | Ebling Keith J. | Exec. VP and Gen. C ... | Sell | S | 78.50 | 16,139 | 1,266,928 | 22,222 | 38.4 K to 22.2 K (-42.07 %) |
| Mar 11 2014 | ESRX | Express Scripts Ho ... | Ebling Keith J. | Exec. VP and Gen. C ... | Buy | M | 49.50 | 9,901 | 490,050 | 38,361 | 28.5 K to 38.4 K (+34.79 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Wimberly Gary | Sr. VP & Ch. Inform ... | Option Exercise | A | 77.15 | 28,795 | 2,221,534 | 28,795 | |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Wimberly Gary | Sr. VP & Ch. Inform ... | Grant | A | 0.00 | 6,740 | 0 | 23,621 | 16.9 K to 23.6 K (+39.93 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Wimberly Gary | Sr. VP & Ch. Inform ... | Payment of Exercise | F | 77.15 | 2,635 | 203,290 | 16,881 | 19.5 K to 16.9 K (-13.50 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Wimberly Gary | Sr. VP & Ch. Inform ... | Grant | A | 0.00 | 6,452 | 0 | 19,516 | 13.1 K to 19.5 K (+49.39 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | WENTWORTH TIMOTHY C | President | Option Exercise | A | 77.15 | 94,140 | 7,262,901 | 94,140 | |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | WENTWORTH TIMOTHY C | President | Grant | A | 0.00 | 22,034 | 0 | 101,303 | 79.3 K to 101.3 K (+27.80 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Wade Sara E | Sr. VP, Ch. Human R ... | Option Exercise | A | 77.15 | 38,071 | 2,937,178 | 38,071 | |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Wade Sara E | Sr. VP, Ch. Human R ... | Grant | A | 0.00 | 8,911 | 0 | 29,532 | 20.6 K to 29.5 K (+43.21 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Wade Sara E | Sr. VP, Ch. Human R ... | Payment of Exercise | F | 77.15 | 1,797 | 138,639 | 20,621 | 22.4 K to 20.6 K (-8.02 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Wade Sara E | Sr. VP, Ch. Human R ... | Grant | A | 0.00 | 5,346 | 0 | 22,418 | 17.1 K to 22.4 K (+31.31 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | STERNBERG SEYMOUR | Director | Option Exercise | M | 30.83 | 13,128 | 404,736 | 0 | |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | STERNBERG SEYMOUR | Director | Sell | S | 76.50 | 13,128 | 1,004,305 | 3,278 | 16.4 K to 3.3 K (-80.02 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | STERNBERG SEYMOUR | Director | Buy | M | 30.83 | 13,128 | 404,736 | 16,406 | 3.3 K to 16.4 K (+400.49 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Stettin Glen D. | Sr. VP, Clin. Res. ... | Option Exercise | A | 77.15 | 23,996 | 1,851,291 | 23,996 | |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Stettin Glen D. | Sr. VP, Clin. Res. ... | Grant | A | 0.00 | 5,616 | 0 | 26,193 | 20.6 K to 26.2 K (+27.29 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Smith Catherine R | Exec. VP & CFO | Option Exercise | A | 77.15 | 50,761 | 3,916,211 | 50,761 | |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Smith Catherine R | Exec. VP & CFO | Grant | A | 0.00 | 25,923 | 0 | 37,804 | 11.9 K to 37.8 K (+218.19 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Smith Catherine R | Exec. VP & CFO | Grant | A | 0.00 | 11,881 | 0 | 11,881 | 0 to 11.9 K |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | PAZ GEORGE | Chairman & CEO | Option Exercise | A | 77.15 | 221,506 | 17,089,188 | 221,506 | |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | PAZ GEORGE | Chairman & CEO | Grant | A | 0.00 | 32,404 | 0 | 788,253 | 755.8 K to 788.3 K (+4.29 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | PAZ GEORGE | Chairman & CEO | Payment of Exercise | F | 77.15 | 35,651 | 2,750,475 | 755,849 | 791.5 K to 755.8 K (-4.50 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | PAZ GEORGE | Chairman & CEO | Grant | A | 0.00 | 74,349 | 0 | 791,500 | 717.2 K to 791.5 K (+10.37 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Norton David A | Senior VP, Supply C ... | Option Exercise | A | 77.15 | 26,303 | 2,029,276 | 26,303 | |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Norton David A | Senior VP, Supply C ... | Grant | A | 0.00 | 6,156 | 0 | 11,071 | 4.9 K to 11.1 K (+125.25 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Miller Steven B | Sr. VP & Chief Med. ... | Option Exercise | A | 77.15 | 20,304 | 1,566,454 | 20,304 | |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Miller Steven B | Sr. VP & Chief Med. ... | Grant | A | 0.00 | 4,752 | 0 | 34,081 | 29.3 K to 34.1 K (+16.20 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Miller Steven B | Sr. VP & Chief Med. ... | Payment of Exercise | F | 77.15 | 1,776 | 137,018 | 29,329 | 31.1 K to 29.3 K (-5.71 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Miller Steven B | Sr. VP & Chief Med. ... | Grant | A | 0.00 | 5,346 | 0 | 31,105 | 25.8 K to 31.1 K (+20.75 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | McNamee Patrick | Exec. VP and COO | Payment of Exercise | F | 77.15 | 6,101 | 470,692 | 52,865 | 59 K to 52.9 K (-10.35 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | McNamee Patrick | Exec. VP and COO | Grant | A | 0.00 | 12,722 | 0 | 58,966 | 46.2 K to 59 K (+27.51 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | IGNACZAK EDWARD B | Exec. VP, Sales and ... | Option Exercise | A | 77.15 | 45,593 | 3,517,500 | 45,593 | |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | IGNACZAK EDWARD B | Exec. VP, Sales and ... | Grant | A | 0.00 | 10,671 | 0 | 85,882 | 75.2 K to 85.9 K (+14.19 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | IGNACZAK EDWARD B | Exec. VP, Sales and ... | Payment of Exercise | F | 77.15 | 6,189 | 477,481 | 75,211 | 81.4 K to 75.2 K (-7.60 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | IGNACZAK EDWARD B | Exec. VP, Sales and ... | Grant | A | 0.00 | 12,907 | 0 | 81,400 | 68.5 K to 81.4 K (+18.84 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Houston Christine | Sr. Vice President, ... | Option Exercise | A | 77.15 | 30,457 | 2,349,758 | 30,457 | |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Houston Christine | Sr. Vice President, ... | Grant | A | 0.00 | 7,128 | 0 | 22,397 | 15.3 K to 22.4 K (+46.68 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Ebling Keith J. | Exec. VP and Gen. C ... | Option Exercise | M | 49.50 | 36,809 | 1,821,861 | 9,901 | |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Ebling Keith J. | Exec. VP and Gen. C ... | Option Exercise | A | 77.15 | 49,838 | 3,845,002 | 49,838 | |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Ebling Keith J. | Exec. VP and Gen. C ... | Option Exercise | M | 22.87 | 102,882 | 2,352,911 | 0 | |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Ebling Keith J. | Exec. VP and Gen. C ... | Option Exercise | M | 22.87 | 22,504 | 514,666 | 0 | |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Ebling Keith J. | Exec. VP and Gen. C ... | Option Exercise | M | 31.92 | 11,226 | 358,334 | 0 | |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Ebling Keith J. | Exec. VP and Gen. C ... | Option Exercise | M | 31.92 | 3,250 | 103,740 | 0 | |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Ebling Keith J. | Exec. VP and Gen. C ... | Sell | S | 78.59 | 10,319 | 811,011 | 33,317 | 43.6 K to 33.3 K (-23.65 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Ebling Keith J. | Exec. VP and Gen. C ... | Sell | S | 77.00 | 21,702 | 1,671,054 | 43,636 | 65.3 K to 43.6 K (-33.21 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Ebling Keith J. | Exec. VP and Gen. C ... | Sell | S | 78.57 | 5,640 | 443,112 | 29,582 | 35.2 K to 29.6 K (-16.01 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Ebling Keith J. | Exec. VP and Gen. C ... | Sell | S | 77.00 | 27,478 | 2,115,806 | 35,222 | 62.7 K to 35.2 K (-43.82 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Ebling Keith J. | Exec. VP and Gen. C ... | Sell | S | 77.00 | 23,638 | 1,820,126 | 0 | 23.6 K to 0 (-100.00 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Ebling Keith J. | Exec. VP and Gen. C ... | Sell | S | 78.50 | 36,809 | 2,889,543 | 28,460 | 65.3 K to 28.5 K (-56.40 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Ebling Keith J. | Exec. VP and Gen. C ... | Buy | M | 49.50 | 36,809 | 1,821,861 | 65,269 | 28.5 K to 65.3 K (+129.34 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Ebling Keith J. | Exec. VP and Gen. C ... | Sell | S | 77.03 | 169,781 | 13,078,061 | 28,460 | 198.2 K to 28.5 K (-85.64 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Ebling Keith J. | Exec. VP and Gen. C ... | Buy | M | 22.87 | 102,882 | 2,352,911 | 198,241 | 95.4 K to 198.2 K (+107.89 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Ebling Keith J. | Exec. VP and Gen. C ... | Buy | M | 22.87 | 22,504 | 514,666 | 95,359 | 72.9 K to 95.4 K (+30.89 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Ebling Keith J. | Exec. VP and Gen. C ... | Buy | M | 31.92 | 11,226 | 358,334 | 72,855 | 61.6 K to 72.9 K (+18.22 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Ebling Keith J. | Exec. VP and Gen. C ... | Buy | M | 31.92 | 3,250 | 103,740 | 61,629 | 58.4 K to 61.6 K (+5.57 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Ebling Keith J. | Exec. VP and Gen. C ... | Grant | A | 0.00 | 11,665 | 0 | 59,279 | 47.6 K to 59.3 K (+24.50 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Ebling Keith J. | Exec. VP and Gen. C ... | Payment of Exercise | F | 77.15 | 5,747 | 443,381 | 47,614 | 53.4 K to 47.6 K (-10.77 %) |
| Mar 07 2014 | ESRX | Express Scripts Ho ... | Ebling Keith J. | Exec. VP and Gen. C ... | Grant | A | 0.00 | 11,985 | 0 | 53,361 | 41.4 K to 53.4 K (+28.97 %) |
| Mar 04 2014 | ESRX | Express Scripts Ho ... | PAZ GEORGE | Chairman & CEO | Payment of Exercise | F | 75.31 | 15,324 | 1,154,050 | 717,151 | 732.5 K to 717.2 K (-2.09 %) |
| Mar 04 2014 | ESRX | Express Scripts Ho ... | Stettin Glen D. | Sr. VP, Clin. Res. ... | Payment of Exercise | F | 75.31 | 904 | 68,080 | 20,577 | 21.5 K to 20.6 K (-4.21 %) |
| Mar 04 2014 | ESRX | Express Scripts Ho ... | Stettin Glen D. | Sr. VP, Clin. Res. ... | Payment of Exercise | F | 74.08 | 2,441 | 180,829 | 21,481 | 23.9 K to 21.5 K (-10.20 %) |
| Mar 04 2014 | ESRX | Express Scripts Ho ... | WENTWORTH TIMOTHY C | President | Payment of Exercise | F | 75.31 | 1,210 | 91,125 | 79,269 | 80.5 K to 79.3 K (-1.50 %) |
| Mar 04 2014 | ESRX | Express Scripts Ho ... | McNamee Patrick | Exec. VP and COO | Payment of Exercise | F | 75.31 | 6,532 | 491,925 | 46,244 | 52.8 K to 46.2 K (-12.38 %) |
| Mar 04 2014 | ESRX | Express Scripts Ho ... | Wimberly Gary | Sr. VP & Ch. Inform ... | Payment of Exercise | F | 75.31 | 3,066 | 230,900 | 13,064 | 16.1 K to 13.1 K (-19.01 %) |
| Mar 04 2014 | ESRX | Express Scripts Ho ... | Wade Sara E | Sr. VP, Ch. Human R ... | Payment of Exercise | F | 75.31 | 2,635 | 198,442 | 17,072 | 19.7 K to 17.1 K (-13.37 %) |
| Mar 04 2014 | ESRX | Express Scripts Ho ... | Miller Steven B | Sr. VP & Chief Med. ... | Payment of Exercise | F | 75.31 | 1,742 | 131,190 | 25,759 | 27.5 K to 25.8 K (-6.33 %) |
| Mar 04 2014 | ESRX | Express Scripts Ho ... | Norton David A | Senior VP, Supply C ... | Payment of Exercise | F | 75.31 | 539 | 40,592 | 4,915 | 5.5 K to 4.9 K (-9.88 %) |
| Mar 04 2014 | ESRX | Express Scripts Ho ... | Knibb Christopher K | VP & Chief Accounti ... | Payment of Exercise | F | 75.31 | 222 | 16,719 | 1,497 | 1.7 K to 1.5 K (-12.91 %) |
| Mar 04 2014 | ESRX | Express Scripts Ho ... | IGNACZAK EDWARD B | Exec. VP, Sales and ... | Payment of Exercise | F | 75.31 | 6,573 | 495,013 | 68,493 | 75.1 K to 68.5 K (-8.76 %) |
| Mar 04 2014 | ESRX | Express Scripts Ho ... | Houston Christine | Sr. VP, Operations | Payment of Exercise | F | 75.31 | 1,315 | 99,033 | 15,269 | 16.6 K to 15.3 K (-7.93 %) |
| Mar 04 2014 | ESRX | Express Scripts Ho ... | Ebling Keith J. | Exec. VP and Gen. C ... | Payment of Exercise | F | 75.31 | 4,782 | 360,132 | 41,376 | 46.2 K to 41.4 K (-10.36 %) |